Two Years versus One Year of Tianjiu Therapy in Sanfu Days for Chronic Asthma: A Clinical Efficacy Observation Trial
Table 2
Variable on asthma patients in 1 course and 2 courses.
Variable
1st baseline
1st posttreatment
2nd baseline
2nd posttreatment
1st posttreatment versus 1st baseline (95% CI)/ value
2nd posttreatment versus 1st baseline (95% CI)/ value
2nd posttreatment versus 1st posttreatment (95% CI)/ value
Asthma-related symptoms—number of daysa
8.44 ± 0.99
1.98 ± 0.99
6.94 ± 0.99
5.03 ± 0.99
−6.46 (−9.21 to −3.72)###
−3.41 (−6.16 to −0.67)#
3.05 (0.30 to 5.80)#
Lung function
FEV
1.86 ± 0.09
2.01 ± 0.09
1.80 ± 0.09
1.76 ± 0.09
0.15 (−0.11 to 0.40)
−0.10 (−0.36 to 0.15)
−0.25 (−0.51 to 0.003)
FEV1:FVC × 100
85.24 ± 1.87
84.72 ± 1.87
81.89 ± 1.87
84.56 ± 1.50
−0.52 (−5.70 to 4.67)
−0.68 (−5.86 to 4.51)
−0.16 (−5.35 to 5.03)
Symptoms which frequently appeared in asthma patients—number of symptomsb
8.20 ± 0.41
2.93 ± 0.41
7.88 ± 0.41
4.31 ± 0.41
−5.27 (−6.40 to −4.13)###
−3.88 (−0.50 to −2.75)###
1.38 (0.25 to 2.51)#
Asthma-related health care use—number (%)
≥1 Admitted to A and Ec
23 (23)
1 (1)
16 (16)
6 (6)
0.000###
0.000###
0.054
≥1 Hospitalization
19 (19)
0 (0)
11 (11)
2 (2)
0.000###
0.000###
0.153
≥1 outpatient visit
60 (59)
9 (9)
52 (51)
50 (49)
0.000###
0.000###
0.000###
≥1 Prescription
72 (71)
61 (60)
79 (77)
70 (69)
0.066
0.758
0.102
≥1 Buy medication
11 (11)
1 (1)
13 (13)
8 (8)
0.001##
0.437
0.006##
≥1 Not to be processed
10 (10)
2 (2)
15 (15)
10 (10)
0.018#
1.000
0.018#
; ; .
aPlus-minus values are means ± SE, unless noted otherwise. PIF denotes peak inspiratory flow; PEF: peak expiratory flow; FEV1: forced expiratory volume in one second; FVC: forced vital capacity.
bThe total number of symptoms which frequently appeared in asthma patients is 23 and its scale ranges from 0 to 23.
cAccident and Emergency Departments (A and E).
